S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.98 (-0.75%)
MSFT   410.60 (-0.26%)
META   485.96 (-0.03%)
GOOGL   143.55 (-0.37%)
AMZN   174.24 (-0.19%)
TSLA   194.58 (-1.43%)
NVDA   792.33 (+0.88%)
NIO   5.42 (-7.35%)
AMD   176.34 (-3.04%)
BABA   76.14 (+0.03%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   153.27 (+1.05%)
DIS   106.52 (-1.04%)
AMC   4.37 (-1.13%)
PFE   27.96 (+1.49%)
PYPL   59.24 (+1.53%)
XOM   103.75 (-0.96%)
S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.98 (-0.75%)
MSFT   410.60 (-0.26%)
META   485.96 (-0.03%)
GOOGL   143.55 (-0.37%)
AMZN   174.24 (-0.19%)
TSLA   194.58 (-1.43%)
NVDA   792.33 (+0.88%)
NIO   5.42 (-7.35%)
AMD   176.34 (-3.04%)
BABA   76.14 (+0.03%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   153.27 (+1.05%)
DIS   106.52 (-1.04%)
AMC   4.37 (-1.13%)
PFE   27.96 (+1.49%)
PYPL   59.24 (+1.53%)
XOM   103.75 (-0.96%)
S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.98 (-0.75%)
MSFT   410.60 (-0.26%)
META   485.96 (-0.03%)
GOOGL   143.55 (-0.37%)
AMZN   174.24 (-0.19%)
TSLA   194.58 (-1.43%)
NVDA   792.33 (+0.88%)
NIO   5.42 (-7.35%)
AMD   176.34 (-3.04%)
BABA   76.14 (+0.03%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   153.27 (+1.05%)
DIS   106.52 (-1.04%)
AMC   4.37 (-1.13%)
PFE   27.96 (+1.49%)
PYPL   59.24 (+1.53%)
XOM   103.75 (-0.96%)
S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.98 (-0.75%)
MSFT   410.60 (-0.26%)
META   485.96 (-0.03%)
GOOGL   143.55 (-0.37%)
AMZN   174.24 (-0.19%)
TSLA   194.58 (-1.43%)
NVDA   792.33 (+0.88%)
NIO   5.42 (-7.35%)
AMD   176.34 (-3.04%)
BABA   76.14 (+0.03%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   153.27 (+1.05%)
DIS   106.52 (-1.04%)
AMC   4.37 (-1.13%)
PFE   27.96 (+1.49%)
PYPL   59.24 (+1.53%)
XOM   103.75 (-0.96%)
OTCMKTS:ASNB

EKIMAS (ASNB) Stock Price, News & Analysis

$0.50
0.00 (0.00%)
(As of 02/22/2024 ET)
Today's Range
$0.50
$0.50
50-Day Range
$0.49
$0.70
52-Week Range
$0.55
$1.75
Volume
N/A
Average Volume
3,162 shs
Market Capitalization
$2.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About EKIMAS

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

ASNB Stock Price History

ASNB Stock News Headlines

The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
EKIMAS Corporation (ASNB)
See More Headlines
Receive ASNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EKIMAS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/16/2014
Today
2/23/2024
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:ASNB
Employees
11
Year Founded
N/A

Profitability

Net Income
$-290,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.03 per share

Miscellaneous

Free Float
5,347,000
Market Cap
$2.90 million
Optionable
Not Optionable
Beta
0.37
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Henrik Rouf
    Chief Executive Officer
  • Bennett J. Yankowitz
    Chief Financial Officer & Director














ASNB Stock Analysis - Frequently Asked Questions

How have ASNB shares performed in 2024?

EKIMAS's stock was trading at $0.62 at the beginning of the year. Since then, ASNB stock has decreased by 19.4% and is now trading at $0.50.
View the best growth stocks for 2024 here
.

How were EKIMAS's earnings last quarter?

EKIMAS Co. (OTCMKTS:ASNB) released its quarterly earnings results on Thursday, October, 16th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.02. During the same quarter last year, the company posted $0.27 EPS.

What other stocks do shareholders of EKIMAS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EKIMAS investors own include NVIDIA (NVDA), Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Biosciences (IDXG), Sphere 3D (ANY), AVEO Pharmaceuticals (AVEO), Boeing (BA) and Bank of America (BAC).

How do I buy shares of EKIMAS?

Shares of ASNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ASNB) was last updated on 2/23/2024 by MarketBeat.com Staff